ZFP30 Activators
ZFP30 can influence the protein's activity through various intracellular signaling pathways, primarily by modulating the phosphorylation state of the protein. Forskolin, Isoproterenol, 8-Bromo-cAMP, and Dibutyryl-cAMP all raise intracellular cyclic AMP (cAMP) levels, thereby activating protein kinase A (PKA). The activation of PKA can lead to the direct phosphorylation of ZFP30, assuming it is a substrate for this kinase. Furthermore, PKA activation can initiate a cascade of events within the cell that indirectly lead to the modification and activation of ZFP30. Anisomycin triggers the activation of stress-activated protein kinases, including JNK, which could phosphorylate ZFP30 as part of a cellular response to stress. Similarly, Epigallocatechin gallate (EGCG) engages with AMP-activated protein kinase (AMPK), which upon activation, may phosphorylate and activate ZFP30 if it is within AMPK's range of target proteins.
Ionomycin and A-23187 increase intracellular calcium concentrations, which can activate calcium-dependent proteins like calmodulin-dependent kinase (CaMK). CaMK can then phosphorylate ZFP30, assuming it is regulated by calcium/calmodulin signaling. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is another kinase that can phosphorylate a broad range of substrates, potentially including ZFP30. Moreover, Calyculin A and Okadaic acid inhibit protein phosphatases such as PP1 and PP2A, which typically dephosphorylate proteins. By preventing the dephosphorylation of proteins, these inhibitors can lead to an increased phosphorylation state of ZFP30, resulting in its maintained or enhanced activation. Lastly, the PKA inhibitor H-89 can lead to the upregulation of compensatory pathways that might involve ZFP30, culminating in the activation of this protein through an alternative route.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which can then phosphorylate various proteins. Given that ZFP30 is a protein that might be regulated by calcium signaling pathways, ionomycin can lead to its activation through CaMK-mediated phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in regulating numerous proteins through phosphorylation. If ZFP30 is a substrate for PKC or is regulated downstream of PKC signaling, PMA could activate ZFP30 by enhancing its phosphorylation state. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, similarly to forskolin, and thereby activates PKA. The activation of PKA can lead to the phosphorylation and subsequent activation of ZFP30 if ZFP30 is a PKA substrate or is otherwise regulated by PKA-mediated signaling. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that directly activates PKA. By mimicking cAMP, it can activate PKA and potentially lead to the activation of ZFP30 through phosphorylation if ZFP30 is within the PKA regulatory network. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases (SAPKs) like JNK. Activation of JNK can lead to the phosphorylation of various target proteins, potentially including ZFP30, thereby activating ZFP30 as part of the response to stress signaling. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which prevents the dephosphorylation of proteins. By inhibiting PP1 and PP2A, Calyculin A could cause an increase in the phosphorylation state of ZFP30, assuming ZFP30 is a target of these phosphatases, leading to its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A-23187 is another calcium ionophore like ionomycin that increases intracellular calcium levels. This can activate calcium-dependent signaling pathways, potentially leading to the activation of ZFP30 through phosphorylation or other calcium-dependent regulatory mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cAMP analog that is cell-permeable and can activate PKA. Through PKA activation, it can lead to the phosphorylation and activation of ZFP30 if it is a part of the PKA signaling cascade. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to have various effects on cellular signaling pathways, including activation of AMP-activated protein kinase (AMPK). Activation of AMPK can lead to subsequent phosphorylation and activation of downstream proteins, which could include ZFP30, assuming ZFP30 is regulated by AMPK signaling. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of PP1 and PP2A, similar to Calyculin A, leading to increased phosphorylation of proteins. If ZFP30 is normally dephosphorylated by these phosphatases, inhibition by Okadaic acid could result in the activation of ZFP30. | ||||||